Ketomycin suppressed cellular migration and invasion in breast carcinoma cells, inhibited NF-κB activity used in upstream signaling by hindering the autophosphorylation of IKK-α/IKK-β, and minimized the 3D-invasion of breast carcinoma cells at nontoxic concentrations [130]. Here, IKBKB is linked to breast carcinoma.